High Dose Rate Brachytherapy as a Boost for the Treatment of Localized Prostate Cancer

Journal of Urology

Volumn 177, Issue 1, 2007, Pages 123-127

  Phan, Thinh P ^a   Syed, A M Nisar ^b   Puthawala, Ajmel ^b   Sharma, Anil ^b   Khan, Farhan ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

brachytherapy; prostate; prostatic neoplasms; radiotherapy; toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RATING SCALE; RECTUM DISEASE; RISK FACTOR; UNIVARIATE ANALYSIS; URINE RETENTION; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 33845300525     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.109     Document Type: Article

References (19)

1. Pollack A., Zagars G.K., Starkschall G., Antolak J., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097
2. Horwitz E.M., Hanlon A.L., Pinover W.H., Anderson P.R., and Hanks G.E. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer 92 (2001) 1281
3. Martinez A.A., Gustafson G., Gonzalez J., Armour E., Mitchell C., Edmunson G., et al. Dose escalation using conformal high dose rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 316
4. Vicini F.A., Vargas C., Edmundson G., Kestin L., and Martinez A. The role of high dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 13 (2003) 98
5. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095
6. Brenner D.J., Martinez A.A., Edmundson G.K., Mitchell C., Thames H., and Armour E.P. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6
7. Fowler J., Chappell R., and Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021
8. Wang J.Z., Li X.A., Yu C.X., and DiBiase S.J. The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 57 (2003) 1101
9. th ed. (2002), Lippincott Publishers, Philadelphia
10. Syed A.M., Puthawala A., Sharma A., Gamie S., Londrc A., Cherlow J., et al. High dose rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control 8 (2001) 511
11. nd ed. (1999), National Cancer Institute, Bethesda
12. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 447
13. Cox D.R. Regression models and life table. J Royal Stat Soc 34 (1971) 187
14. Galalae R.M., Martinez A., Mate T., Mitchell C., Edmunson G., Nuernberg N., et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1048
15. Demanes D.J., Rodriguez R.R., Schour L., Brandt D., and Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306
16. Pilepich M.V., Krall J.M., Al-Sarraf M., John M.D., Doggett R.L., Sause W.T., et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45 (1995) 616
17. Bolla M., Gonzalez D., Warde P., Dubois J.B., Mirimanoff R.O., Storme G., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295
18. Martinez A.A., Demanes D.J., Galalae R., Vargas C., Bertermann H., Rodriguez R., et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regimen. Int J Radiat Oncol Biol Phys 62 (2005) 1322
19. Pellizzon A.C., Salvajoli J.V., Maia M.A., Ferrigno R., Novaes P.E., Fogarolli R.C., et al. Late urinary morbidity with high dose rate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J. Urology 171 (2004) 1105